Related Experiment Video
Updated: Jun 20, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Inflammation, autoimmunity, and atherosclerosis
1Research and Development, Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543, USA. qihong.zhao@bms.com
Atherosclerosis, traditionally linked to high cholesterol, is increasingly recognized as an inflammatory and immune-driven disease. New research explores novel diagnostic and therapeutic strategies targeting these inflammatory pathways.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Pathogenesis of Atherosclerosis
Background:
- Atherosclerosis has historically been associated with dyslipidemia, a known risk factor.
- Lipid-lowering statin therapies have demonstrated efficacy in reducing cardiovascular events.
Purpose of the Study:
- To review clinical and preclinical evidence supporting atherosclerosis as an inflammatory disease.
- To present evidence for atherosclerosis as an autoimmune disease.
- To discuss novel diagnostic and therapeutic opportunities and challenges.
Main Methods:
- Review of preclinical research.
- Analysis of clinical studies.
- Examination of immunological and inflammatory markers.
Main Results:
- Growing evidence indicates inflammation and immune responses are integral to atherosclerosis pathogenesis.
- Atherosclerosis exhibits characteristics of an autoimmune disease.
Conclusions:
- Atherosclerosis is fundamentally an inflammatory and immune-mediated condition.
- Translating this understanding into new diagnostics and therapies presents opportunities and challenges.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Inflammation
Atherosclerosis I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Inflammation: Introduction
Coronary Artery Disease I: Introduction
